Research and Markets has announced the addition of the "Urinary Tract Infections - Pipeline Insights, 2017" drug pipelines to their offering.

Urinary Tract Infections - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Urinary Tract Infections.

The This report covers the product profiles in various stages of development including Discovery, Pre - clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.

This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Urinary Tract Infections.

This report also assesses the Urinary Tract Infections therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Key Topics Covered:

  1. Urinary Tract Infections Overview
  2. Urinary Tract Infections Disease Associated
  3. Urinary Tract Infections Pipeline Therapeutics
  4. Urinary Tract Infections Therapeutics under Development by Companies
  5. Urinary Tract Infections Filed and Phase III Products
  6. Urinary Tract Infections Phase II Products
  7. Urinary Tract Infections Phase I and IND Filed Products
  8. Urinary Tract Infections Discovery and Pre-Clinical Stage Products
  9. Drug Candidate Profiles
  10. Urinary Tract Infections - Therapeutics Assessment
  11. Urinary Tract Infections - Discontinued Products
  12. Urinary Tract Infections - Dormant Products
  13. Companies Involved in Therapeutics Development for Urinary Tract Infections
  14. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/2rcdvt/urinary_tract